--- title: "Decoy Therapeutics expands IP portfolio with 1 granted US patent, 19 applications pending" type: "News" locale: "en" url: "https://longbridge.com/en/news/294697289.md" description: "Decoy Therapeutics has expanded its antiviral intellectual property portfolio to seven patent families, securing one granted U.S. patent (No. 12,226,474) for antiviral peptide conjugates and maintaining 19 pending applications. These pending filings cover manufacturing methods, engineered conjugates, formulations, and a June 2026 application related to its IMP³ACT design platform." datetime: "2026-08-03T13:01:32.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/294697289.md) - [en](https://longbridge.com/en/news/294697289.md) - [zh-HK](https://longbridge.com/zh-HK/news/294697289.md) generator: "portal-rs" --- # Decoy Therapeutics expands IP portfolio with 1 granted US patent, 19 applications pending - Decoy Therapeutics expanded its antiviral intellectual property portfolio to seven patent families, including one granted U.S. patent and 19 pending applications. \* U.S. Patent No. 12,226,474 covers antiviral peptide conjugates that incorporate viral spike protein sequences with D-amino acids. \* Pending filings cover manufacturing methods, engineered antiviral conjugates, formulations, and a June 2026 application tied to its IMP³ACT design platform. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Decoy Therapeutics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202608030900PR\_NEWS\_USPR\_\_\_\_\_NE17644) on August 03, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) ### Related Stocks - [DCOY.US](https://longbridge.com/en/quote/DCOY.US.md) ## Related News & Research - [Warner Music Stock And The Copyright Fight Reshaping Music Rights Investing](https://longbridge.com/en/news/297543553.md) - [Virtual Mind targets AI platform buildout with HK$5 million from share placing proceeds](https://longbridge.com/en/news/297298083.md) - [11:18 ETVeteran First-Chair Trial Lawyer Mary-Olga "Mo" Lovett Joins McKool Smith](https://longbridge.com/en/news/297065642.md) - [General Mills (GIS) Stock Looks Fairly Priced While Its Broader Checks Look Weak](https://longbridge.com/en/news/297413782.md) - [15:10 ETHas Anyone Tried Gundry MD Vital Reds? Read Reviews, Ingredients, Benefits & More](https://longbridge.com/en/news/297553063.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**